For example, while BRCA1 mutations are associated with a 50–85% lifetime risk of breast cancer and consideration of prophylactic mastectomy may be appropriate, ATM mutations are associated with more moderate risks that may warrant screening with a breast magnetic resonance imaging (MRI) but not necessarily consideration of prophylactic mastectomy. Here, ATM is linked to breast carcinoma.